Viewing nowCombinationJartana Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.

MFDS item code 200700388 · Notified 2007.01.10 · Insurance code 652901490
Treatment of hypertension not controlled with monotherapy
You are in a state of hypertension where blood pressure control is insufficient with monotherapy. In this case, it is important to manage blood pressure more effectively through additional medication or combination therapy. Proper treatment helps stabilize blood pressure and reduce the risk of complications. These medications are used in the treatment of hypertension.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. In general, the maximum blood pressure-lowering effect is achieved approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, treatment with this medicine should be initiated only when the desired effect is not achieved with monotherapy. 1. Replacement therapy: Combination therapy with individually adjusted doses of losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Initiate treatment with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Initiate treatment with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia even when their blood pressure is controlled at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which allows a reduction in the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. The clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg should then be monitored continuously. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose may be administered to patients with creatinine clearance of 30 mL/min or greater. Use in patients with more severe renal impairment is not recommended, as loop diuretics are preferred over thiazide diuretics in these patients. ○ Patients with hepatic impairment Use in these patients is not recommended because the initial dose of losartan potassium for patients with hepatic impairment requiring dose adjustment, 25 mg, cannot be administered with this medicine.
Pediatric patients (under 18 years): There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication can cause serious harm to the fetus, especially when taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with certain conditions; for example, patients with anuria, those allergic to certain drugs, patients with severe hepatic or renal impairment, and pregnant women should not take this medication. Additionally, this medication should be used cautiously in patients with hypotension or impaired renal function, those with hyperuricemia or gout, and elderly patients, as there may be an increased risk of skin cancer. Sunlight exposure should be avoided and skin conditions should be routinely checked. During treatment with this medication, blood pressure, electrolyte levels, and renal function should be regularly monitored to ensure there are no abnormalities, as electrolyte imbalances such as hypokalemia or hyperkalemia may occur. This medication can interact with other drugs, so it is essential to consult a physician when taking it alongside potassium supplements, potassium-containing medications, certain diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs). Dizziness, drowsiness, coughing, and allergic reactions may occur during treatment; if any of these symptoms develop, inform your medical provider immediately. There is limited experience with this medication in children and adolescents, so it is not recommended for these age groups. Additionally, caution is required in the elderly as they may have a higher incidence of adverse reactions. Finally, this medication should be stored away from direct sunlight and kept out of reach of children, preferably in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that protects it from light, maintaining a temperature between 1°C and 30°C at room temperature. This will help maintain the effectiveness of the medication and prevent deterioration.
Yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.